ElevateBio, LLC Insider Profile
11 Followers
ElevateBio, LLC, Director, Ten Percent Owner at Kalaris Therapeutics, holds 16.67M shares in Kalaris Therapeutics (Ticker: KLRS).
ElevateBio, LLC's Trading History
| KLRSKalaris Therapeutics | Aug 01, 2022 | Director, Ten Percent Owner | Uninformative Buy | 15.00M | $26.26M | |
KLRS Insider Shares: 16.67M (25.49%) ElevateBio, LLC has not reported any informative transactions for KLRS, therefore, performance cannot be measured. | ||||||
You May Also Like
ElevateBio, LLC insider profile FAQ
What stocks does ElevateBio, LLC hold?
ElevateBio, LLC holds: KLRS stocks.
What was ElevateBio, LLC’s latest transaction?
ElevateBio, LLC’s latest transaction was an Uninformative Buy of $15.00M.
What is ElevateBio, LLC's role in Kalaris Therapeutics?
ElevateBio, LLC's role in Kalaris Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
